It’s back to school and back to work! Get into the swing of things by catching up on the latest news in the research ethics world (which never goes on vacation)!
Aveo Reeling after FDA's Rejection of Kidney Cancer Drug: Aveo Pharmaceuticals spent seven years and $300 million developing tivozanib, a kidney cancer drug, which was recently rejected by the [...] Read more
by Elisa A. Hurley, PhD, Education Director
Those who have been following the Surfactant, Positive Pressure, and Oxygenation Randomized Trial (SUPPORT) controversy know that the story has continued to unfold over the past month. Here I review several of the latest developments, some of which may have wide implications for the human research protections [...] Read more
